Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconINSMInsmed$31.32bnn/an/a
us flag iconIQVIqvia Holdings$27.50bn19.56n/a
us flag iconBNTXBioNTech SE$21.53bnn/an/a
us flag iconEXASExact Sciences$20.03bnn/an/a
us flag iconRVMDRevolution Medicines$18.33bnn/an/a
us flag iconASNDAscendis Pharma A/S$13.45bnn/an/a
us flag iconSMMTSummit Therapeutics$12.86bnn/an/a
us flag iconMEDPMedpace Holdings$12.81bn29.53n/a
us flag iconRGCRegencell Bioscience Holdings$12.69bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconIONSIonis Pharmaceuticals$11.92bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$11.71bnn/an/a
us flag iconEXELExelixis$10.79bn14.64n/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconBPMCBlueprint Medicines$8.37bnn/an/a
us flag iconCERECerevel Therapeutics Holdings$8.19bnn/an/a
us flag iconARWRArrowhead Pharmaceuticals$8.09bn37.5n/a
us flag iconPRAXPraxis Precision Medicines$8.08bnn/an/a